These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 19604265)

  • 1. The glutamic acid decarboxylase 65 immunoglobulin G subclass profile differs between adult-onset type 1 diabetes and latent autoimmune diabetes in adults (LADA) up to 3 years after clinical onset.
    Hillman M; Törn C; Landin-Olsson M;
    Clin Exp Immunol; 2009 Aug; 157(2):255-60. PubMed ID: 19604265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgG4-subclass of glutamic acid decarboxylase antibody is more frequent in latent autoimmune diabetes in adults than in type 1 diabetes.
    Hillman M; Törn C; Thorgeirsson H; Landin-Olsson M
    Diabetologia; 2004 Nov; 47(11):1984-9. PubMed ID: 15565370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence of glutamic acid decarboxylase antibody (GADA) is associated with clinical characteristics of latent autoimmune diabetes in adults: a prospective study with 3-year follow-up.
    Huang G; Yin M; Xiang Y; Li X; Shen W; Luo S; Lin J; Xie Z; Zheng P; Zhou Z
    Diabetes Metab Res Rev; 2016 Sep; 32(6):615-22. PubMed ID: 26787598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutamic acid decarboxylase 65 autoantibody levels discriminate two subtypes of latent autoimmune diabetes in adults.
    Li X; Yang L; Zhou Z; Huang G; Yan X
    Chin Med J (Engl); 2003 Nov; 116(11):1728-32. PubMed ID: 14642146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies to N-terminally truncated GAD improve clinical phenotyping of individuals with adult-onset diabetes: Action LADA 12.
    Achenbach P; Hawa MI; Krause S; Lampasona V; Jerram ST; Williams AJK; Bonifacio E; Ziegler AG; Leslie RD;
    Diabetologia; 2018 Jul; 61(7):1644-1649. PubMed ID: 29619531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Identification of the two subtypes of latent autoimmune diabetes in adults by glutamic acid decarboxylase 65 antibody titers].
    Li X; Zhou ZG; Huang G; Yan X; Yang L; Hu BY
    Zhonghua Nei Ke Za Zhi; 2003 Jan; 42(1):7-10. PubMed ID: 12757655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency, immunogenetics, and clinical characteristics of latent autoimmune diabetes in China (LADA China study): a nationwide, multicenter, clinic-based cross-sectional study.
    Zhou Z; Xiang Y; Ji L; Jia W; Ning G; Huang G; Yang L; Lin J; Liu Z; Hagopian WA; Leslie RD;
    Diabetes; 2013 Feb; 62(2):543-50. PubMed ID: 23086039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgG1 is the dominant subclass of antibody against glutamic acid decarboxylase among type 1 diabetes in Japanese.
    Kasuga A; Shimada A; Ozawa Y; Maruyama T; Oya K; Saruta T
    Endocr J; 2000 Feb; 47(1):57-62. PubMed ID: 10811294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GADA titer-related risk for organ-specific autoimmunity in LADA subjects subdivided according to gender (NIRAD study 6).
    Zampetti S; Capizzi M; Spoletini M; Campagna G; Leto G; Cipolloni L; Tiberti C; Bosi E; Falorni A; Buzzetti R;
    J Clin Endocrinol Metab; 2012 Oct; 97(10):3759-65. PubMed ID: 22865904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Metabolic syndrome and latent autoimmune diabetes in adults].
    Li X; Zhou ZG; Yang L; Huang G; Yan X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Dec; 25(6):676-9. PubMed ID: 14714310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgG4 subclass glutamic acid decarboxylase antibodies (GADA) are associated with a reduced risk of developing type 1 diabetes as well as increased C-peptide levels in GADA positive gestational diabetes.
    Dereke J; Nilsson C; Strevens H; Landin-Olsson M; Hillman M
    Clin Immunol; 2016 Jan; 162():45-8. PubMed ID: 26548838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GAD antibodies in T1D and LADA--relations to age, BMI, c-peptide, IA-2 and HLA-DRB1*03 and DRB1*04 alleles.
    Weber P; Ambrosova P; Canov P; Weberova D; Kuklinek P; Meluzinova H; Matejovska-Kubesova H; Cejkova P; Bielakova K; Cerna M
    Adv Gerontol; 2011; 24(2):312-8. PubMed ID: 21957594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamic Acid Decarboxylase Autoantibody Detection by Electrochemiluminescence Assay Identifies Latent Autoimmune Diabetes in Adults with Poor Islet Function.
    Zhu Y; Qian L; Liu Q; Zou J; Zhou Y; Yang T; Huang G; Zhou Z; Liu Y
    Diabetes Metab J; 2020 Apr; 44(2):260-266. PubMed ID: 31769235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of LADA and frequency of GAD antibodies in diabetic patients with end-stage renal disease and dialysis treatment in Austria.
    Biesenbach G; Auinger M; Clodi M; Prischl F; Kramar R;
    Nephrol Dial Transplant; 2005 Mar; 20(3):559-65. PubMed ID: 15671073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of glutamic acid decarboxylase antibodies (GADA) IgG subclasses - comparison of three immunoprecipitation assays (IPAs).
    Hillman M; Törn C; Landin-Olsson M
    Clin Exp Immunol; 2007 Oct; 150(1):68-74. PubMed ID: 17666094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence and characteristics of latent autoimmune diabetes in adults (LADA) and its relation with chronic complications in a clinical department of a university hospital in Korea.
    Roh MO; Jung CH; Kim BY; Mok JO; Kim CH
    Acta Diabetol; 2013 Apr; 50(2):129-34. PubMed ID: 20953640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High titre of antiglutamic acid decarboxylase autoantibody is a strong predictor of the development of thyroid autoimmunity in patients with type 1 diabetes and latent autoimmune diabetes in adults.
    Jin P; Huang G; Lin J; Yang L; Xiang B; Zhou W; Zhou Z
    Clin Endocrinol (Oxf); 2011 May; 74(5):587-92. PubMed ID: 21470281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender differences in GAD antibody-positive diabetes mellitus in relation to age at onset, C-peptide and other endocrine autoimmune diseases.
    Lindholm E; Hallengren B; Agardh CD
    Diabetes Metab Res Rev; 2004; 20(2):158-64. PubMed ID: 15037992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associated autoimmunity in Type 1 Diabetes and latent autoimmune diabetes of adults: The role of glutamic-acid decarboxylase autoantibodies.
    Gougourelas D; Tsentidis C; Koufadaki AM; Koutsovasilis A; Gougourela E; Karanasios S; Sotiropoulos A; Bousboulas S; Karavanaki KA
    Diabetes Res Clin Pract; 2021 May; 175():108847. PubMed ID: 33945840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latent autoimmune diabetes in adults with low-titer GAD antibodies: similar disease progression with type 2 diabetes: a nationwide, multicenter prospective study (LADA China Study 3).
    Liu L; Li X; Xiang Y; Huang G; Lin J; Yang L; Zhao Y; Yang Z; Hou C; Li Y; Liu J; Zhu D; Leslie RD; Wang X; Zhou Z;
    Diabetes Care; 2015 Jan; 38(1):16-21. PubMed ID: 25336751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.